Healthcare Affordability
Expert articles and analysis related to healthcare affordability.
AI Summary â Last 24 Hours
Federal affordability policy is tightening around Medicaid and Medicare: a Senate Budget Committee hearing kept pressure on One Big Beautiful Bill Act Medicaid provisions, with conservative lawmakers arguing federal cuts and work requirements can streamline spending while providers and states face coverage-loss and uncompensated-care riskâespecially for rural and homeless populations (HFMA). For VBC organizations, the immediate concern is attribution and risk-pool disruption as Medicaid eligibility churn, ACA marketplace morbidity reportedly worsens, and Medicare Advantage plans like Clover Health lean on membership growth and Star Ratings to improve outlooksâraising the stakes for population health infrastructure, risk adjustment, and retention. CMS also released the FY 2026 IPPS final rule, while scrutiny of Medicare drug price-negotiation timing signals continued affordability pressure across hospital payment, Part D economics, and total-cost-of-care models.
Related Articles
STAT+: Medicare quietly gave blockbuster AbbVie drug seven extra years before price negotiations, advocacy group asserts
A little-noticed government policy shift caused a seven-year delay in choosing a costly medicine for Medicare price negotiations, an advocacy group says.
How Much and Why Premiums Are Going Up for Small Businesses in 2027
Small businesses that offer health insurance to their employees could see health costs rise in 2027, according to an analysis of preliminary rate filings from all 50 states and DC. Nearly 300 insurers...
Myths Of Mandatory International Reference Pricing For Prescription Drugs
Myths Of Mandatory International Reference Pricing For Prescription Drugs  Health Affairs
Judge signs off on Teva's $35M settlement over delayed inhaler generics
A Massachusetts federal judge on Wednesday approved a $35 million settlement between Teva Pharmaceuticals and a handful of healthcare funds over allegations the company delayed generic versions of its...
Arizona erases $1B in medical debt
Arizona erases $1B in medical debt  Becker's Hospital Review
HRSA to Launch Revised 340B Rebate Model Next Year
HRSA to Launch Revised 340B Rebate Model Next Year  American Health Law Association
On Cell And Gene Therapies, Payers And Providers Should Collaborate To Enhance Access And Affordability
On Cell And Gene Therapies, Payers And Providers Should Collaborate To Enhance Access And Affordability  Health Affairs
Senate Working Group Releases Bipartisan Measure to Reform 340B Program
Senate Working Group Releases Bipartisan Measure to Reform 340B Program  American Health Law Association
Building on Statesâ Medical Debt Protections: Closing Gaps in Standards, Access, and Enforcement
Building on Statesâ Medical Debt Protections: Closing Gaps in Standards, Access, and Enforcement  Commonwealth Fund
Highly Novel Drugs Outperformed Less Novel Drugs In Gross And Net Revenues In The US, Driven Primarily By Utilization, 2013â19
Highly Novel Drugs Outperformed Less Novel Drugs In Gross And Net Revenues In The US, Driven Primarily By Utilization, 2013â19Â Â Health Affairs